322 related articles for article (PubMed ID: 32997798)
1. Immunogenic characteristics of microsatellite instability-low esophagogastric junction adenocarcinoma based on clinicopathological, molecular, immunological and survival analyses.
Imamura Y; Toihata T; Haraguchi I; Ogata Y; Takamatsu M; Kuchiba A; Tanaka N; Gotoh O; Mori S; Nakashima Y; Oki E; Mori M; Oda Y; Taguchi K; Yamamoto M; Morita M; Yoshida N; Baba H; Mine S; Nunobe S; Sano T; Noda T; Watanabe M
Int J Cancer; 2021 Mar; 148(5):1260-1275. PubMed ID: 32997798
[TBL] [Abstract][Full Text] [Related]
2. Recent Incidence Trend of Surgically Resected Esophagogastric Junction Adenocarcinoma and Microsatellite Instability Status in Japanese Patients.
Imamura Y; Watanabe M; Toihata T; Takamatsu M; Kawachi H; Haraguchi I; Ogata Y; Yoshida N; Saeki H; Oki E; Taguchi K; Yamamoto M; Morita M; Mine S; Hiki N; Baba H; Sano T
Digestion; 2019; 99(1):6-13. PubMed ID: 30554205
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract][Full Text] [Related]
4. Microsatellite instability in esophageal adenocarcinoma.
Evans SC; Gillis A; Geldenhuys L; Vaninetti NM; Malatjalian DA; Porter GA; Guernsey DL; Casson AG
Cancer Lett; 2004 Aug; 212(2):241-51. PubMed ID: 15279904
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of PD-L1 protein expression, EBV positivity, and MSI status in patients with advanced gastric and esophagogastric junction adenocarcinoma in Japan.
Yoshida T; Ogura G; Tanabe M; Hayashi T; Ohbayashi C; Azuma M; Kunisaki C; Akazawa Y; Ozawa S; Matsumoto S; Suzuki T; Mitoro A; Fukunaga T; Shimizu A; Fujimoto G; Yao T
Cancer Biol Ther; 2022 Dec; 23(1):191-200. PubMed ID: 35220884
[TBL] [Abstract][Full Text] [Related]
6. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic characteristics of colorectal cancer with microsatellite instability.
Ziadi S; Ksiaa F; Ben Gacem R; Labaied N; Mokni M; Trimeche M
Pathol Res Pract; 2014 Feb; 210(2):98-104. PubMed ID: 24286815
[TBL] [Abstract][Full Text] [Related]
8. Immuno-Oncology Biomarkers for Gastric and Gastroesophageal Junction Adenocarcinoma: Why PD-L1 Testing May Not Be Enough.
Weinberg BA; Xiu J; Hwang JJ; Shields AF; Salem ME; Marshall JL
Oncologist; 2018 Oct; 23(10):1171-1177. PubMed ID: 29703766
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and polymorphism of Bethesda panel markers in Chinese population.
Zheng Y; Chen J; Zhang X; Xie L; Zhang Y; Sun Y
Bull Cancer; 2020 Nov; 107(11):1091-1097. PubMed ID: 32980144
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implication of molecular subtypes and response to neoadjuvant chemotherapy in 760 gastric carcinomas: role of Epstein-Barr virus infection and high- and low-microsatellite instability.
Kohlruss M; Grosser B; Krenauer M; Slotta-Huspenina J; Jesinghaus M; Blank S; Novotny A; Reiche M; Schmidt T; Ismani L; Hapfelmeier A; Mathias D; Meyer P; Gaida MM; Bauer L; Ott K; Weichert W; Keller G
J Pathol Clin Res; 2019 Oct; 5(4):227-239. PubMed ID: 31206244
[TBL] [Abstract][Full Text] [Related]
11. Improved testing for microsatellite instability in colorectal cancer using a simplified 3-marker assay.
Esemuede I; Forslund A; Khan SA; Qin LX; Gimbel MI; Nash GM; Zeng Z; Rosenberg S; Shia J; Barany F; Paty PB
Ann Surg Oncol; 2010 Dec; 17(12):3370-8. PubMed ID: 20703819
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability in poorly differentiated adenocarcinomas of the colon and rectum: relationship to clinicopathological features.
Kazama Y; Watanabe T; Kanazawa T; Tanaka J; Tanaka T; Nagawa H
J Clin Pathol; 2007 Jun; 60(6):701-4. PubMed ID: 17557871
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.
Sugimoto R; Sugai T; Habano W; Endoh M; Eizuka M; Yamamoto E; Uesugi N; Ishida K; Kawasaki T; Matsumoto T; Suzuki H
Int J Cancer; 2016 Apr; 138(7):1689-97. PubMed ID: 26538087
[TBL] [Abstract][Full Text] [Related]
14. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.
Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC
Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability--MSI markers (BAT26, BAT25, D2S123, D5S346, D17S250) in rectal cancer.
Losso GM; Moraes Rda S; Gentili AC; Messias-Reason IT
Arq Bras Cir Dig; 2012; 25(4):240-4. PubMed ID: 23411922
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability of each tumor in sporadic synchronous multiple colorectal cancers.
Abe Y; Masuda H; Okubo R
Oncol Rep; 2001; 8(2):299-304. PubMed ID: 11182044
[TBL] [Abstract][Full Text] [Related]
17. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability.
Gafà R; Maestri I; Matteuzzi M; Santini A; Ferretti S; Cavazzini L; Lanza G
Cancer; 2000 Nov; 89(10):2025-37. PubMed ID: 11066042
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the Three Customized MSI Panels to Improve the Detection of Microsatellite Instability in Gastric Cancer.
Park J; Shin S; Yoo HM; Lee SW; Kim JG
Clin Lab; 2017 Apr; 63(4):705-716. PubMed ID: 28397474
[TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases.
Warth A; Körner S; Penzel R; Muley T; Dienemann H; Schirmacher P; von Knebel-Doeberitz M; Weichert W; Kloor M
Virchows Arch; 2016 Mar; 468(3):313-9. PubMed ID: 26637197
[TBL] [Abstract][Full Text] [Related]
20. Programmed Death-Ligand 1 Expression Is Common in Gastric Cancer Associated With Epstein-Barr Virus or Microsatellite Instability.
Ma C; Patel K; Singhi AD; Ren B; Zhu B; Shaikh F; Sun W
Am J Surg Pathol; 2016 Nov; 40(11):1496-1506. PubMed ID: 27465786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
